Mouse model of NASH that replicates key features of the human disease and progresses to fibrosis stage 3

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States and the world; with no Food and Drug Administration–approved pharmacological treatment available, it remains an area of unmet medical need. In nonalcoholic steatohepatitis (NASH), the most important predic...

Descripción completa

Detalles Bibliográficos
Autores principales: St. Rose, Kristy, Yan, Jun, Xu, Fangxi, Williams, Jasmine, Dweck, Virginia, Saxena, Deepak, Schwabe, Robert F., Caviglia, Jorge Matias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512466/
https://www.ncbi.nlm.nih.gov/pubmed/35923109
http://dx.doi.org/10.1002/hep4.2035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512466/
https://www.ncbi.nlm.nih.gov/pubmed/35923109
http://dx.doi.org/10.1002/hep4.2035

Ejemplares similares